News
EVGN
0.7100
+0.64%
0.0045
Evogene Ltd. Announces Upcoming Annual Meeting
TipRanks · 4d ago
Weekly Report: what happened at EVGN last week (0422-0426)?
Weekly Report · 6d ago
Weekly Report: what happened at EVGN last week (0415-0419)?
Weekly Report · 04/22 10:41
Weekly Report: what happened at EVGN last week (0408-0412)?
Weekly Report · 04/15 10:34
Analysts Offer Insights on Healthcare Companies: Evogene (EVGN), Edwards Lifesciences (EW) and Nurix Therapeutics (NRIX)
TipRanks · 04/11 11:50
Weekly Report: what happened at EVGN last week (0401-0405)?
Weekly Report · 04/08 10:37
Evogene’s New Venture Targets Sustainable Protein Market
TipRanks · 04/02 11:57
EVOGENE LTD - EVOGENE AND KITCHEN FOODTECH HUB ESTABLISHED FINALLY FOODS LTD.
Reuters · 04/02 11:04
EVOGENE LTD - EVOGENE HOLDS APPROXIMATELY 40% STAKE IN 'FINALLY FOODS'
Reuters · 04/02 11:04
Evogene (EVGN) Receives a Buy from Lake Street
TipRanks · 04/01 12:55
Weekly Report: what happened at EVGN last week (0325-0329)?
Weekly Report · 04/01 10:36
Evogene Ltd. Announces $7.3 Million Share Sale Plan
TipRanks · 03/29 01:30
Weekly Report: what happened at EVGN last week (0318-0322)?
Weekly Report · 03/25 10:39
Evogene Ltd. Faces Nasdaq Compliance Challenge
TipRanks · 03/20 13:27
Evogene gets non-compliance notice from Nasdaq
Healthcare Evogene gets non-compliance notice from Nasdaq. Evogene has until September 16 to regain compliance with the minimum bid price requirement. The company said it received a letter from the Nasdaq stating that the company is not in compliance. ETEvogene Ltd.
Seeking Alpha · 03/20 13:20
Weekly Report: what happened at EVGN last week (0311-0315)?
Weekly Report · 03/18 10:37
Weekly Report: what happened at EVGN last week (0304-0308)?
Weekly Report · 03/11 10:35
EVGN Stock Earnings: Evogene Beats EPS, Misses Revenue for Q4 2023
Evogene reported earnings per share of -13 cents. The company reported revenue of $578,000. This was 36.48% worse than the analyst estimate of $910,000 for the company's quarterly report. Evogene also reported lower than expected revenue for the quarter.
Investorplace · 03/07 17:53
Israeli Company Reports Record 2023 Revenue, Wants To Transition Cannabis Operations To 'Third Party'
Evogene Ltd. Announced Thursday its financial results for the fourth quarter and full-year period ending December 31, 2023. The Rehovot, Israel-based cannabis company reported $5.6 million in revenue for 2023, a year-over-year increase of 237% from $1.7 million.
Benzinga · 03/07 14:20
Evogene (EVGN) Reports Q4 Loss, Misses Revenue Estimates
NASDAQ · 03/07 14:20
More
Webull provides a variety of real-time EVGN stock news. You can receive the latest news about Evogene through multiple platforms. This information may help you make smarter investment decisions.
About EVGN
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.